209 related articles for article (PubMed ID: 22693688)
1. Biochemical and medical importance of vanadium compounds.
Korbecki J; Baranowska-Bosiacka I; Gutowska I; Chlubek D
Acta Biochim Pol; 2012; 59(2):195-200. PubMed ID: 22693688
[TBL] [Abstract][Full Text] [Related]
2. Organo-vanadium compounds are potent activators of the protein kinase B signaling pathway and protein tyrosine phosphorylation: mechanism of insulinomimesis.
Mehdi MZ; Srivastava AK
Arch Biochem Biophys; 2005 Aug; 440(2):158-64. PubMed ID: 16055077
[TBL] [Abstract][Full Text] [Related]
3. Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.
Ścibior A; Pietrzyk Ł; Plewa Z; Skiba A
J Trace Elem Med Biol; 2020 Sep; 61():126508. PubMed ID: 32305626
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
5. [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus].
Beliaeva NF; Gorodetskiĭ VK; Tochilkin AI; Golubev MA; Semenova NV; Kovel'man IR
Vopr Med Khim; 2000; 46(4):344-60. PubMed ID: 11075417
[TBL] [Abstract][Full Text] [Related]
6. Insulino-mimetic and anti-diabetic effects of vanadium compounds.
Srivastava AK; Mehdi MZ
Diabet Med; 2005 Jan; 22(1):2-13. PubMed ID: 15606684
[TBL] [Abstract][Full Text] [Related]
7. Vanadyl(IV) complexes with saccharides. Bioactivity in osteoblast-like cells in culture.
Barrio DA; Cattáneo ER; Apezteguía MC; Etcheverry SB
Can J Physiol Pharmacol; 2006 Jul; 84(7):765-75. PubMed ID: 16998540
[TBL] [Abstract][Full Text] [Related]
8. [Insulin-mimetic property of vanadium compounds].
Korbecki J; Baranowska-Bosiacka I; Gutowska I; Chlubek D
Postepy Biochem; 2016; 62(1):60-65. PubMed ID: 28132446
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic, Chemical, and Physical Properties of Organic Vanadates as Presumed Transition-State Inhibitors for Phosphatases.
Crans DC
J Org Chem; 2015 Dec; 80(24):11899-915. PubMed ID: 26544762
[TBL] [Abstract][Full Text] [Related]
10. Antitumoral properties of two new vanadyl(IV) complexes in osteoblasts in culture: role of apoptosis and oxidative stress.
Molinuevo MS; Barrio DA; Cortizo AM; Etcheverry SB
Cancer Chemother Pharmacol; 2004 Feb; 53(2):163-72. PubMed ID: 14551736
[TBL] [Abstract][Full Text] [Related]
11. The potentiality of vanadium in medicinal applications.
Rehder D
Future Med Chem; 2012 Sep; 4(14):1823-37. PubMed ID: 23043479
[TBL] [Abstract][Full Text] [Related]
12. Vanadium pentoxide induces activation and death of endothelial cells.
Montiel-Dávalos A; Gonzalez-Villava A; Rodriguez-Lara V; Montaño LF; Fortoul TI; López-Marure R
J Appl Toxicol; 2012 Jan; 32(1):26-33. PubMed ID: 21721017
[TBL] [Abstract][Full Text] [Related]
13. Developing Vanadium as an Antidiabetic or Anticancer Drug: A Clinical and Historical Perspective.
Crans DC; Henry L; Cardiff G; Posner BI
Met Ions Life Sci; 2019 Jan; 19():. PubMed ID: 30855109
[TBL] [Abstract][Full Text] [Related]
14. Vanadium and the cardiovascular functions.
Coderre L; Srivastava AK
Can J Physiol Pharmacol; 2004 Oct; 82(10):833-9. PubMed ID: 15573143
[TBL] [Abstract][Full Text] [Related]
15. Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats.
Li M; Smee JJ; Ding W; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):585-9. PubMed ID: 19203797
[TBL] [Abstract][Full Text] [Related]
16. Vanadium compounds induced mitochondria permeability transition pore (PTP) opening related to oxidative stress.
Zhao Y; Ye L; Liu H; Xia Q; Zhang Y; Yang X; Wang K
J Inorg Biochem; 2010 Apr; 104(4):371-8. PubMed ID: 20015552
[TBL] [Abstract][Full Text] [Related]
17. Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate.
Willsky GR; Chi LH; Liang Y; Gaile DP; Hu Z; Crans DC
Physiol Genomics; 2006 Aug; 26(3):192-201. PubMed ID: 16684804
[TBL] [Abstract][Full Text] [Related]
18. Vanadium Compounds as Pro-Inflammatory Agents: Effects on Cyclooxygenases.
Korbecki J; Baranowska-Bosiacka I; Gutowska I; Chlubek D
Int J Mol Sci; 2015 Jun; 16(6):12648-68. PubMed ID: 26053397
[TBL] [Abstract][Full Text] [Related]
19. Potential use of vanadium compounds in therapeutics.
Barrio DA; Etcheverry SB
Curr Med Chem; 2010; 17(31):3632-42. PubMed ID: 20846114
[TBL] [Abstract][Full Text] [Related]
20. Is the hypoglycemic action of vanadium compounds related to the suppression of feeding?
Huang M; Wu Y; Wang N; Wang Z; Zhao P; Yang X
Biol Trace Elem Res; 2014 Mar; 157(3):242-8. PubMed ID: 24446192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
